{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:12:56Z","timestamp":1778854376052,"version":"3.51.4"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL 153532"],"award-info":[{"award-number":["R01 HL 153532"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R35 HL161177"],"award-info":[{"award-number":["R35 HL161177"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL 149825"],"award-info":[{"award-number":["R01 HL 149825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL162787"],"award-info":[{"award-number":["R01 HL162787"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R33 HL157609"],"award-info":[{"award-number":["R33 HL157609"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 GM125944"],"award-info":[{"award-number":["R01 GM125944"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["19EIA34770095"],"award-info":[{"award-number":["19EIA34770095"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["R01 HL162787"],"award-info":[{"award-number":["R01 HL162787"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["R33 HL157609"],"award-info":[{"award-number":["R33 HL157609"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["5KL2TR001856-07"],"award-info":[{"award-number":["5KL2TR001856-07"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["R01 GM125944"],"award-info":[{"award-number":["R01 GM125944"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.redox.2023.102941","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T04:53:17Z","timestamp":1698123197000},"page":"102941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Fatty acid nitroalkenes \u2013 Multi-target agents for the treatment of sickle cell disease"],"prefix":"10.1016","volume":"68","author":[{"given":"Fabliha A.","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Colussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine C.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia Z.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9526-695X","authenticated-orcid":false,"given":"Francisco J.","family":"Schopfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam C.","family":"Straub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2023.102941_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","author":"Kato","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.redox.2023.102941_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1910.00050330050003","article-title":"Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia","author":"Herrick","year":"1910","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.redox.2023.102941_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2014.11011","article-title":"Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia","author":"Herrick","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.redox.2023.102941_bib4","article-title":"Low pH induced shape changes and vesiculation of human erythrocytes","author":"Gros","year":"1996","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.redox.2023.102941_bib5","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","author":"Sundd","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.redox.2023.102941_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: towards a multi-agent approach","volume":"18","author":"Telen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2023.102941_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2020.00435","article-title":"Recent advances in the treatment of sickle cell disease","volume":"11","author":"Salinas Cisneros","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.redox.2023.102941_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cophys.2019.04.022","article-title":"Redox signaling in sickle cell disease","author":"Nolfi-Donegan","year":"2019","journal-title":"Current Opinion in Physiology"},{"key":"10.1016\/j.redox.2023.102941_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101072","article-title":"The impact of xanthine oxidase (XO) on hemolytic diseases","author":"Schmidt","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102941_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions","author":"Kato","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.redox.2023.102941_bib11","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0891-5849(02)00993-0","article-title":"Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases","volume":"33","author":"Baldus","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2023.102941_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/00062752-200303000-00001","article-title":"An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy","author":"Reiter","year":"2003","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.redox.2023.102941_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/S0162-0134(00)80291-3","article-title":"Oxidation of nitrogen oxides by bound dioxygen in hemoproteins","author":"Doyle","year":"1981","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.redox.2023.102941_bib14","doi-asserted-by":"crossref","DOI":"10.1021\/bi960442g","article-title":"Mechanism of NO-induced oxidation of myoglobin and hemoglobin","author":"Eich","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2023.102941_bib15","doi-asserted-by":"crossref","DOI":"10.1021\/bi002407m","article-title":"Kinetic and mechanistic studies of the NO\u2022-mediated oxidation of oxymyoglobin and oxyhemoglobin","author":"Herold","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2023.102941_bib16","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcibr023045","article-title":"Hemoglobin and the paracrine and endocrine functions of nitric oxide","author":"Schechter","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.102941_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/nbt0798-672","article-title":"Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin","author":"Doherty","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.redox.2023.102941_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.redox.2023.102941_bib19","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201111-2082CI","article-title":"Pulmonary complications of sickle cell disease","author":"Miller","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.redox.2023.102941_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.redox.2023.102941_bib21","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI26857","article-title":"Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice","author":"Belcher","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2023.102941_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.hoc.2013.11.006","article-title":"Inflammatory mediators of endothelial injury in sickle cell disease","author":"Hoppe","year":"2014","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.redox.2023.102941_bib24","series-title":"Hypercoagulability in Sickle Cell Disease: New Approaches to an Old Problem. Hematology\/the Education Program of the American Society of Hematology","author":"Ataga","year":"2007"},{"key":"10.1016\/j.redox.2023.102941_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjh.14112","article-title":"Microparticles in sickle cell anaemia: promise and pitfalls","volume":"174","author":"Hebbel","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.redox.2023.102941_bib26","doi-asserted-by":"crossref","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","author":"Tomer","year":"2001","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.redox.2023.102941_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-013-0895-y","article-title":"Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know","author":"Naik","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.redox.2023.102941_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","author":"Kato","year":"2007","journal-title":"Blood Rev."},{"key":"10.1016\/j.redox.2023.102941_bib29","first-page":"S335","article-title":"Sickle cell disease: current treatment and emerging therapies","volume":"25","author":"Neumayr","year":"2019","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.redox.2023.102941_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.24557","article-title":"Sickle cell disease related mortality in the United States (1999-2009)","author":"Hamideh","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.redox.2023.102941_bib31","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V91.12.4472","article-title":"Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients","author":"Maier-Redelsperger","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib32","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2003-07-2475","article-title":"Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease","author":"Zimmerman","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib33","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial","author":"Kinney","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib34","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2017-02-765891","article-title":"Treating sickle cell disease by targeting HbS polymerization","author":"Eaton","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib35","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.11515","article-title":"Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males","author":"Berthaut","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.redox.2023.102941_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14656566.2014.868435","article-title":"The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease","volume":"15","author":"Kassim","year":"2014","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.redox.2023.102941_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/genes12071096","article-title":"Hydroxyurea\u2014the good, the bad and the ugly","author":"Musia\u0142ek","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.redox.2023.102941_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002202.pub2","article-title":"Hydroxyurea (hydroxycarbamide) for sickle cell disease","author":"Nevitt","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.redox.2023.102941_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOP.0b013e328321882e","article-title":"Current issues in blood transfusion for sickle cell disease","volume":"21","author":"Wahl","year":"2009","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.redox.2023.102941_bib40","article-title":"Surgical management of sickle cell anemia: the use of packed red blood cell transfusions","author":"MADEL","year":"1958","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.redox.2023.102941_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/S0037-1963(01)90025-3","article-title":"Principles and problems of transfusion in sickle cell disease","author":"Telen","year":"2001","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.redox.2023.102941_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<122::AID-JCA3>3.0.CO;2-A","article-title":"Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload","author":"Singer","year":"1999","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.redox.2023.102941_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/2040620713483063","article-title":"Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions","author":"Shenoy","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.redox.2023.102941_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.hemonc.2017.05.008","article-title":"Hematopoietic stem cell transplantation for sickle cell disease: the changing landscape","author":"Kassim","year":"2017","journal-title":"Hematology\/Oncology and Stem Cell Therapy"},{"key":"10.1016\/j.redox.2023.102941_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100925","article-title":"L-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: hype or hope?","volume":"53","author":"Leibovitch","year":"2022","journal-title":"Blood Rev."},{"key":"10.1016\/j.redox.2023.102941_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/1535370219900637","article-title":"L-glutamine for sickle cell disease: knight or pawn?","author":"Sadaf","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.redox.2023.102941_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/1060028020943059","article-title":"Voxelotor: a novel treatment for sickle cell disease","author":"Herity","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.redox.2023.102941_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/phar.2409","article-title":"Systematic review of crizanlizumab: a new parenteral option to reduce vaso-occlusive pain crises in patients with sickle cell disease","author":"Han","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.redox.2023.102941_bib49","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l -glutamine in sickle cell disease","author":"Niihara","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.102941_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24975","article-title":"Sickle hemoglobin oxygen affinity-shifting strategies have unequal cerebrovascular risks","author":"Hebbel","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.redox.2023.102941_bib51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00277-021-04728-0","article-title":"The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease","volume":"101","author":"Souli\u00e8res","year":"2022","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.redox.2023.102941_bib52","doi-asserted-by":"crossref","DOI":"10.1177\/014107680209500909","article-title":"Management of pain in sickle-cell disease","author":"Okpala","year":"2002","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.redox.2023.102941_bib53","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-3470","article-title":"Improving the management of vaso-occlusive episodes in the pediatric emergency department","author":"Kavanagh","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.redox.2023.102941_bib54","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bjh.13348","article-title":"Guideline on the management of acute chest syndrome in sickle cell disease","volume":"169","author":"Howard","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.redox.2023.102941_bib55","article-title":"Management of sickle cell disease: recommendations from the 2014 expert panel report","author":"Yawn","year":"2015","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.redox.2023.102941_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/heapol\/czr023","article-title":"Access to emergency and surgical care in sub-Saharan Africa: the infrastructure gap","author":"Hsia","year":"2012","journal-title":"Health Pol. Plann."},{"key":"10.1016\/j.redox.2023.102941_bib57","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","author":"Ataga","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.102941_bib58","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1903212","article-title":"A phase 3 randomized trial of voxelotor in sickle cell disease","author":"Vichinsky","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.102941_bib59","series-title":"Crizanlizumab, Voxelotor, and L-Glutamine for Sickle Cell Disease: Effectiveness and Value","author":"Bradt","year":"2020"},{"key":"10.1016\/j.redox.2023.102941_bib60","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3324\/haematol.2018.207357","article-title":"Emerging disease-modifying therapies for sickle cell disease","volume":"104","author":"Carden","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.redox.2023.102941_bib61","first-page":"1","article-title":"Emerging therapies for the management of pain and vaso-occlusive crises in patients with sickle cell disease: a systematic review of randomized controlled trials","volume":"15","author":"Lowe","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.redox.2023.102941_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.01297","article-title":"The emerging therapeutic potential of nitro fatty acids and other Michael acceptor-containing drugs for the treatment of inflammation and cancer","volume":"11","author":"Piesche","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2023.102941_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.niox.2018.06.006","article-title":"Nitro-fatty acids: new drug candidates for chronic inflammatory and fibrotic diseases","volume":"79","author":"Schopfer","year":"2018","journal-title":"Nitric Oxide - Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2009.11.003","article-title":"Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment","author":"Khoo","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.redox.2023.102941_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.cophys.2019.04.013","article-title":"Nitrated fatty acids: from diet to disease","author":"Khoo","year":"2019","journal-title":"Current Opinion in Physiology"},{"key":"10.1016\/j.redox.2023.102941_bib66","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M111.225029","article-title":"Electrophilic fatty acids regulate matrix metalloproteinase activity and expression","author":"Bonacci","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-20460-8","article-title":"Electrophilic fatty acid nitroalkenes regulate Nrf2 and NF-\u03baB signaling:A medicinal chemistry investigation of structure-function relationships","volume":"8","author":"Khoo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2023.102941_bib68","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M704085200","article-title":"Nitro-fatty acid reaction with glutathione and cysteine: kinetic analysis of thiol alkylation by a Michael addition reaction","author":"Baker","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib69","doi-asserted-by":"crossref","first-page":"14019","DOI":"10.1074\/jbc.M110.190710","article-title":"Electrophilic nitro-fatty acids activate Nrf2 by a Keap1 cysteine 151-independent mechanism","volume":"286","author":"Kansanen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib70","first-page":"873","article-title":"Characteristics and molecular mechanisms","author":"Villacorta","year":"2017","journal-title":"Front. Biosci."},{"key":"10.1016\/j.redox.2023.102941_bib71","doi-asserted-by":"crossref","first-page":"33233","DOI":"10.1074\/jbc.M109.064873","article-title":"Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid","volume":"284","author":"Kansanen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib72","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M602814200","article-title":"Reversible post-translational modification of proteins by nitrated fatty acids in vivo","author":"Batthyany","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib73","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.niox.2020.06.003","article-title":"Electrophilic nitrated fatty acids are potential therapeutic candidates for inflammatory and fibrotic lung diseases","volume":"102","author":"Panati","year":"2020","journal-title":"Nitric Oxide - Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib74","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431X20133202","article-title":"Nitro-fatty acids: novel anti-inflammatory lipid mediators","author":"Rubbo","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.redox.2023.102941_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-71870-6","article-title":"Nitro-fatty acids suppress ischemic ventricular arrhythmias by preserving calcium homeostasis","volume":"10","author":"Mollenhauer","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2023.102941_bib76","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00321.2015","article-title":"Protection of nitro-fatty acid against kidney diseases","volume":"310","author":"Wang","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.redox.2023.102941_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/617063","article-title":"The nitrated fatty acid 10-nitro-oleate diminishes severity of lps-induced acute lung injury in mice","volume":"2012","author":"Reddy","year":"2012","journal-title":"PPAR Res."},{"key":"10.1016\/j.redox.2023.102941_bib78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1165\/rcmb.2013-0063OC","article-title":"Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension","volume":"51","author":"Klinke","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.redox.2023.102941_bib79","series-title":"Nitro-fatty Acids in Plant Signaling: Nitro-Linolenic Acid Induces the Molecular Chaperone Network in Arabidopsis 1[OPEN] for Advanced Studies in Olive Grove and Olive Oils (C. Plant Physiol. \u00d2","author":"Mata-P\u00e9rez","year":"2016"},{"key":"10.1016\/j.redox.2023.102941_bib80","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/cts.12672","article-title":"Pharmacokinetic and pharmacodynamic effects of oral CXA-10, a nitro fatty acid, after single and multiple ascending doses in healthy and obese subjects","volume":"12","author":"Garner","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.redox.2023.102941_bib81","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.freeradbiomed.2015.07.149","article-title":"Nitrite and nitrate-dependent generation of anti-inflammatory fatty acid nitroalkenes","volume":"89","author":"Delmastro-Greenwood","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2023.102941_bib82","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.109.199075","article-title":"Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury","author":"Cole","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2023.102941_bib83","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.semdp.2011.07.005","article-title":"Pathology of sickle cell disease","volume":"29","author":"Malowany","year":"2012","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.redox.2023.102941_bib84","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-04-1376","article-title":"Evidence for ineffective erythropoiesis in severe sickle cell disease","volume":"106","author":"Wu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2011.08999.x","article-title":"Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients","author":"Brousse","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.redox.2023.102941_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2020.02.005","article-title":"Nrf2 deficiency in mice attenuates erythropoietic stress-related macrophage hypercellularity","author":"Gbotosho","year":"2020","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.redox.2023.102941_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/ncb2699","article-title":"Nrf2 regulates haematopoietic stem cell function","author":"Tsai","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.redox.2023.102941_bib88","doi-asserted-by":"crossref","DOI":"10.1177\/1535370219825859","article-title":"Mechanisms of NRF2 activation to mediate fetal hemoglobin induction and protection against oxidative stress in sickle cell disease","author":"Zhu","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.redox.2023.102941_bib89","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-10-314096","article-title":"Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway","author":"Macari","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib90","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.975.975","article-title":"Induction of \u03b3-globin gene expression via the nrf2\/antioxidant response element signaling pathway","author":"Macari","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib91","article-title":"Loss of NRF2 function exacerbates the pathophysiology of sickle cell disease in a transgenic mouse model","author":"Zhu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.21569","article-title":"Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease","author":"Fitzhugh","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.redox.2023.102941_bib93","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.RES.88.1.12","article-title":"Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease","volume":"88","author":"O'Donnell","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2023.102941_bib94","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","author":"Kolwicz","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2023.102941_bib95","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.freeradbiomed.2009.10.046","article-title":"Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids","volume":"48","author":"Khoo","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2023.102941_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2015.11.002","article-title":"Fatty acid nitroalkenes induce resistance to ischemic cardiac injury by modulating mitochondrial respiration at complex II","volume":"8","author":"Koenitzer","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102941_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.redox.2023.102941_bib98","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.0000258868.80079.4d","article-title":"Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo","author":"Levonen","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2023.102941_bib99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12012-008-9016-0","article-title":"Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress","volume":"8","author":"Zhu","year":"2008","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.redox.2023.102941_bib100","doi-asserted-by":"crossref","DOI":"10.1210\/en.2007-1639","article-title":"Nitroalkenes suppress lipopolysaccharide-induced signal transducer and activator of transcription signaling in macrophages: a critical role of mitogen-activated protein kinase phosphatase 1","author":"Ichikawa","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.redox.2023.102941_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00579","article-title":"Dynamic aspects of macrophage polarization during atherosclerosis progression and regression","author":"Peled","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2023.102941_bib102","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.109.201582","article-title":"Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice","author":"Rudolph","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2023.102941_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvt002","article-title":"Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts","author":"Villacorta","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2023.102941_bib104","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M110.154518","article-title":"Nitroarachidonic acid, a novel peroxidase inhibitor of prostaglandin endoperoxide H synthases 1 and 2","author":"Trostchansky","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib105","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvp275","article-title":"Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion","author":"Rudolph","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2023.102941_bib106","article-title":"Co-treatment with conjugated linoleic acid and nitrite protects against myocardial infarction","author":"Qipshidze-Kelm","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102941_bib107","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease -- life expectancy and risk factors for early death","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.102941_bib108","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease","author":"Vichinsky","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.102941_bib109","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2013.5473","article-title":"Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation","author":"Awwad","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2023.102941_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/JCI43382","article-title":"Disruption of PPAR\u03b3\/\u03b2-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival","author":"Alastalo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2023.102941_bib111","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.90236.2008","article-title":"Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury","author":"Liu","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.redox.2023.102941_bib112","article-title":"Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice","author":"Wang","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.redox.2023.102941_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.25592","article-title":"Renal medullary carcinoma and sickle cell trait: a systematic review","author":"Alvarez","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.redox.2023.102941_bib114","article-title":"Renal medullary carcinoma and sickle cell trait: a push for early diagnosis and intervention report of two cases","author":"Carter","year":"2017","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.redox.2023.102941_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27060","article-title":"Diverse manifestations of acute sickle cell hepatopathy in pediatric patients with sickle cell disease: a case series","author":"Pecker","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.redox.2023.102941_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/0016-5085(86)90276-3","article-title":"Hepatobiliary system in sickle cell disease","author":"Schubert","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2023.102941_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.02.019","article-title":"Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice","author":"Rom","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.redox.2023.102941_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101132","article-title":"Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis","author":"Khoo","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102941_bib119","article-title":"Hepatic manifestations in sickle cell disease","author":"Mishra","year":"1992","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.redox.2023.102941_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96471-9","article-title":"Nitroalkene fatty acids modulate bile acid metabolism and lung function in obese asthma","author":"Manni","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2023.102941_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.pediatrneurol.2019.02.018","article-title":"Sickle cell disease and stroke","author":"Hirtz","year":"2019","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.redox.2023.102941_bib122","doi-asserted-by":"crossref","DOI":"10.2478\/v10039-010-0045-0","article-title":"Neuroimaging in assessment of risk of stroke in children with sickle cell disease","author":"Arkuszewski","year":"2010","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.redox.2023.102941_bib123","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.109.163154","article-title":"Nitro-oleic acid inhibits firing and activates TRPV1- and TRPA1-mediated inward currents in dorsal root ganglion neurons from adult male rats","author":"Sculptoreanu","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.redox.2023.102941_bib124","doi-asserted-by":"crossref","DOI":"10.1113\/jphysiol.2014.271783","article-title":"Activation of TRPC channels contributes to OA-NO2-induced responses in Guinea-pig dorsal root ganglion neurons","author":"Zhang","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.redox.2023.102941_bib125","doi-asserted-by":"crossref","DOI":"10.1179\/146532810X12637745451870","article-title":"Ocular manifestations of sickle cell disease","author":"Fadugbagbe","year":"2010","journal-title":"Ann. Trop. Paediatr."},{"key":"10.1016\/j.redox.2023.102941_bib126","doi-asserted-by":"crossref","first-page":"12617","DOI":"10.1073\/pnas.1006774107","article-title":"Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease","volume":"107","author":"Bradner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2023.102941_bib127","doi-asserted-by":"crossref","DOI":"10.1186\/1472-698X-10-S1-S11","article-title":"The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan","author":"Perampaladas","year":"2010","journal-title":"BMC Int. Health Hum. Right"},{"key":"10.1016\/j.redox.2023.102941_bib128","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood-2022-167997","article-title":"Pharmacodynamic results from phase 1 studies of GBT021601, a next-generation HbS polymerization inhibitor for treatment of sickle cell disease","volume":"140","author":"Idowu","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102941_bib129","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1512021","article-title":"A multinational trial of prasugrel for sickle cell vaso-occlusive events","author":"Heeney","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.102941_bib130","doi-asserted-by":"crossref","DOI":"10.1160\/Th06-12-0718","article-title":"Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial","author":"Qari","year":"2007","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.redox.2023.102941_bib131","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tem.2019.04.009","article-title":"Nitro-fatty acid logistics: formation, biodistribution, signaling, and pharmacology","volume":"30","author":"Schopfer","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.redox.2023.102941_bib132","doi-asserted-by":"crossref","DOI":"10.1007\/s10557-020-07031-8","article-title":"Suppression of vascular macrophage activation by nitro-oleic acid and its implication for abdominal aortic aneurysm therapy","author":"Zhao","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.redox.2023.102941_bib133","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvab256","article-title":"Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome","author":"Nettersheim","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2023.102941_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00131","article-title":"Profile of arachidonic acid-derived inflammatory markers and its modulation by nitro-oleic acid in an inherited model of amyotrophic lateral sclerosis","author":"Trostchansky","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.redox.2023.102941_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2016.07.010","article-title":"Nitro-oleic acid inhibits vascular endothelial inflammatory responses and the endothelial-mesenchymal transition","author":"Ambrozova","year":"2016","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.redox.2023.102941_bib136","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvv254","article-title":"Nitrated fatty acids suppress angiotensin II-mediated fibrotic remodelling and atrial fibrillation","author":"Rudolph","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2023.102941_bib137","article-title":"Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth","author":"Chen Woodcock","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib138","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.AC118.005899","article-title":"Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells","author":"Asan","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169052","article-title":"Nitro-oleic acid (No2-oa) improves systolic function in dilated cardiomyopathy by attenuating myocardial fibrosis","author":"Braumann","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2023.102941_bib140","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M109.091512","article-title":"Covalent peroxisome proliferator-activated receptor \u03b3 adduction by nitro-fatty acids","author":"Schopfer","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102941_bib141","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.110.218404","article-title":"Nitro-oleic acid inhibits angiotensin II-induced hypertension","author":"Zhang","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2023.102941_bib142","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1402965111","article-title":"Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase","author":"Charles","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2023.102941_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.04.001","article-title":"The nitrated fatty acid, 10-nitrooleate inhibits the neutrophil chemotaxis via peroxisome proliferator-activated receptor gamma in CLP-induced sepsis in mice","author":"Panati","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.redox.2023.102941_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2017.11.009","article-title":"Topical electrophilic nitro-fatty acids potentiate cutaneous inflammation","author":"Mathers","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2023.102941_bib145","doi-asserted-by":"crossref","DOI":"10.1111\/all.13067","article-title":"Electrophilic nitro-fatty acids suppress allergic contact dermatitis in mice","author":"Mathers","year":"2017","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"key":"10.1016\/j.redox.2023.102941_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101987","article-title":"Electrophilic nitro-fatty acids suppress psoriasiform dermatitis: STAT3 inhibition as a contributory mechanism","author":"Wang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102941_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2009.11.014","article-title":"Nitrated oleic acid up-regulates PPAR\u03b3 and attenuates experimental inflammatory bowel disease","author":"Borniquel","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2023.102941_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113861","article-title":"Nitro-oleic acid-mediated blood-brain barrier protection reduces ischemic brain injury","author":"Zhou","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.redox.2023.102941_bib149","doi-asserted-by":"crossref","DOI":"10.7150\/ntno.62351","article-title":"Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion","author":"Yu","year":"2022","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.redox.2023.102941_bib150","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00157.2013","article-title":"Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice","author":"Liu","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.redox.2023.102941_bib151","article-title":"Nitro-oleic acid protects against adriamycin-induced nephropathy in mice","author":"Liu","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.redox.2023.102941_bib152","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.118.254755","article-title":"CXA-10, a nitrated fatty acid, is renoprotective in deoxycorticosterone acetate-salt nephropathy","author":"Arbeeny","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.redox.2023.102941_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108838","article-title":"Nitrated fatty acid, 10-nitrooleate protects against hyperoxia-induced acute lung injury in mice","author":"Narala","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.redox.2023.102941_bib154","article-title":"Effects of endogenous PPAR agonist nitro-oleic acid on metabolic syndrome in obese Zucker rats","author":"Yang","year":"2010","journal-title":"PPAR Res."},{"key":"10.1016\/j.redox.2023.102941_bib155","first-page":"1","article-title":"Neuroprotective actions of a fatty acid nitroalkene in Parkinson's disease","volume":"9","author":"Di Maio","year":"2023","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.redox.2023.102941_bib156","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvt341","article-title":"Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity","author":"Kelley","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2023.102941_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121106","article-title":"Administration of nitro-oleic acid mitigates radiation-induced hematopoietic injury in mice","author":"Perecko","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2023.102941_bib158","doi-asserted-by":"crossref","DOI":"10.1089\/ten.tea.2017.0349","article-title":"Nitro-oleic acid (NO2-OA) release enhances regional angiogenesis in a rat abdominal wall defect model","author":"D'Amore","year":"2018","journal-title":"Tissue Eng."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723003427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723003427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:01:14Z","timestamp":1778853674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231723003427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":158,"alternative-id":["S2213231723003427"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2023.102941","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty acid nitroalkenes \u2013 Multi-target agents for the treatment of sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2023.102941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102941"}}